VanEck ETF Trust. Holdings as of Jun 30, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Eli Lilly & CoLLY | 16.56% | $137.93K | 115 |
| Johnson & JohnsonJNJ | 10.67% | $88.89K | 350 |
| AbbVie IncABBV | 7.76% | $64.67K | 257 |
| UnitedHealth Group IncUNH | 6.59% | $54.86K | 132 |
| Merck & Co IncMRK | 5.54% | $46.13K | 359 |
| Amgen IncAMGN | 3.39% | $28.25K | 78 |
| Thermo Fisher Scientific IncTMO | 3.25% | $27.07K | 54 |
| Abbott LaboratoriesABT | 2.76% | $22.96K | 253 |
| Gilead Sciences IncGILD | 2.74% | $22.87K | 181 |
| Intuitive Surgical IncISRG | 2.48% | $20.68K | 52 |
| Pfizer IncPFE | 2.40% | $19.96K | 829 |
| CVS Health CorpCVS | 2.31% | $19.24K | 186 |
| Vertex Pharmaceuticals IncVRTX | 2.21% | $18.38K | 37 |
| Danaher CorpDHR | 2.10% | $17.52K | 92 |
| Bristol-Myers Squibb CoBMY | 2.05% | $17.11K | 297 |
| Stryker CorpSYK | 1.89% | $15.74K | 50 |
| Medtronic PLC | 1.76% | $14.63K | 187 |
| McKesson CorpMCK | 1.54% | $12.85K | 17 |
| Elevance Health IncELV | 1.49% | $12.38K | 32 |
| Cigna Group/TheCI | 1.26% | $10.48K | 38 |
| Regeneron Pharmaceuticals IncREGN | 1.12% | $9.35K | 15 |
| Boston Scientific CorpBSX | 1.11% | $9.22K | 216 |
| HCA Healthcare IncHCA | 1.08% | $8.97K | 23 |
| Cardinal Health IncCAH | 0.97% | $8.08K | 34 |
| Cencora IncCOR | 0.95% | $7.92K | 28 |
| Edwards Lifesciences CorpEW | 0.91% | $7.60K | 84 |
| Humana IncHUM | 0.81% | $6.75K | 17 |
| Becton Dickinson & CoBDX | 0.73% | $6.05K | 40 |
| IDEXX Laboratories IncIDXX | 0.70% | $5.79K | 11 |
| Agilent Technologies IncA | 0.65% | $5.45K | 41 |
| Waters CorpWAT | 0.63% | $5.25K | 14 |
| IQVIA Holdings IncIQV | 0.56% | $4.64K | 24 |
| Biogen IncBIIB | 0.54% | $4.54K | 21 |
| Zoetis IncZTS | 0.53% | $4.38K | 61 |
| Centene CorpCNC | 0.52% | $4.36K | 68 |
| GE HealthCare Technologies IncGEHC | 0.51% | $4.22K | 66 |
| ResMed IncRMD | 0.49% | $4.09K | 21 |
| Veeva Systems IncVEEV | 0.47% | $3.90K | 22 |
| Mettler-Toledo International IncMTD | 0.46% | $3.83K | 3 |
| Dexcom IncDXCM | 0.45% | $3.77K | 56 |
| West Pharmaceutical Services IncWST | 0.43% | $3.59K | 10 |
| Moderna IncMRNA | 0.43% | $3.57K | 51 |
| Quest Diagnostics IncDGX | 0.41% | $3.39K | 16 |
| Labcorp Holdings IncLH | 0.40% | $3.36K | 12 |
| STERIS PLC | 0.35% | $2.95K | 14 |
| Incyte CorpINCY | 0.33% | $2.72K | 24 |
| Viatris IncVTRS | 0.32% | $2.68K | 169 |
| Zimmer Biomet Holdings IncZBH | 0.29% | $2.41K | 28 |
| Cooper Cos Inc/TheCOO | 0.24% | $2.01K | 28 |
| Revvity IncRVTY | 0.21% | $1.78K | 16 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.